Bayesian Capital Management’s Scotiabank BNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-27,190
Closed -$1.76M 171
2025
Q3
$1.76M Buy
+27,190
New +$1.6M 0.36% 84
2024
Q4
Sell
-3,773
Closed -$206K 705
2024
Q3
$206K Buy
+3,773
New +$183K 0.02% 559
2024
Q2
Sell
-33,600
Closed -$1.74M 756
2024
Q1
$1.74M Buy
+33,600
New +$1.61M 0.17% 175
2023
Q4
Sell
-9,800
Closed -$447K 764
2023
Q3
$447K Buy
+9,800
New +$470K 0.05% 396
2023
Q1
Sell
-4,700
Closed -$230K 795
2022
Q4
$230K Buy
+4,700
New +$232K 0.03% 558
2021
Q4
Sell
-9,600
Closed -$591K 385
2021
Q3
$591K Buy
+9,600
New +$600K 0.17% 163
2021
Q2
Sell
-4,344
Closed -$272K 428
2021
Q1
$272K Buy
+4,344
New +$252K 0.06% 371
2020
Q4
Sell
-5,000
Closed -$208K 464
2020
Q3
$208K Sell
5,000
-23,201
-82% -$974K 0.05% 438
2020
Q2
$1.16M Buy
+28,201
New +$1.13M 0.26% 105
2017
Q1
Sell
-4,400
Closed -$245K 422
2016
Q4
$245K Buy
+4,400
New +$240K 0.06% 474

Other funds holding BNS

Bayesian Capital Management's BNS Position: Q4 2025 in Review

Bayesian Capital Management sold out of Scotiabank (BNS) in Q4 2025, closing a stake of 27,190 shares — an estimated $1.76M sold.

Bayesian Capital Management first reported a position in BNS in Q4 2016 and held it in 10 quarters. The position peaked at $1.76M in Q3 2025. 484 funds tracked by Wall St. Rank hold BNS as of Q4 2025.

  • Bayesian Capital Management reported no remaining Scotiabank position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 27,190 Scotiabank shares in Q4 2025, an estimated $1.76M.
  • Bayesian Capital Management first reported a position in Scotiabank in Q4 2016 and held it in 10 quarters.
  • Bayesian Capital Management's Scotiabank position peaked at $1.76M in Q3 2025.
  • 484 funds tracked by Wall St. Rank held Scotiabank as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.